Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell Responses

Vaccines based on mRNA and viral vectors are currently used in the frontline to combat the ongoing pandemic caused by the novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). However, there is still an urgent need for alternative vaccine technologies inducing/boosting long-lasting and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamminen, Kirsi, Heinimäki, Suvi, Gröhn, Stina, Blazevic, Vesna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309989/
https://www.ncbi.nlm.nih.gov/pubmed/34358149
http://dx.doi.org/10.3390/vaccines9070733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309989/
https://www.ncbi.nlm.nih.gov/pubmed/34358149
http://dx.doi.org/10.3390/vaccines9070733

Ejemplares similares